CN105388146B - Kit that is a kind of while detecting sodium in urine, creatinine and microalbumin - Google Patents
Kit that is a kind of while detecting sodium in urine, creatinine and microalbumin Download PDFInfo
- Publication number
- CN105388146B CN105388146B CN201510683512.7A CN201510683512A CN105388146B CN 105388146 B CN105388146 B CN 105388146B CN 201510683512 A CN201510683512 A CN 201510683512A CN 105388146 B CN105388146 B CN 105388146B
- Authority
- CN
- China
- Prior art keywords
- creatinine
- sodium
- solution
- microalbumin
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
- G01N33/683—Total protein determination, e.g. albumin in urine involving metal ions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明提供一种能同时检测尿液中钠、肌酐和微量白蛋白的试剂盒。本发明的试剂盒包括:具有钠反应孔、肌酐反应孔和微量白蛋白反应孔的反应基板;钠稀释液,肌酐稀释液以及三种物质的标准比色板。本发明通过在上述3个反应孔中添加含有不同配置底物、酶溶液的反应垫,实现对尿液中钠、肌酐和微量白蛋白的半定量检测。本发明试剂盒制备方法简单,性能稳定,易保存,不同尿钠、肌酐、微量白蛋白含量对应的色阶明显,便于判定被检测人员的盐量是否超标以及肾脏是否受损,同时适用于医院检验科及非专业检验人员使用。The invention provides a kit capable of simultaneously detecting sodium, creatinine and microalbumin in urine. The kit of the invention comprises: a reaction base plate with a sodium reaction hole, a creatinine reaction hole and a microalbumin reaction hole; a sodium diluent, a creatinine diluent and a standard color comparison plate of the three substances. The present invention realizes semi-quantitative detection of sodium, creatinine and microalbumin in urine by adding reaction pads containing differently configured substrates and enzyme solutions to the above three reaction wells. The preparation method of the kit of the present invention is simple, the performance is stable, and it is easy to store. The color scale corresponding to different urine sodium, creatinine, and trace albumin contents is obvious, which is convenient for judging whether the salt content of the tested person exceeds the standard and whether the kidney is damaged. It is also suitable for hospitals. Laboratory and non-professional inspection personnel use.
Description
技术领域technical field
本发明涉及酶法测定尿液中钠、肌酐和微量白蛋白含量的方法,以及应用该方法配制而成的同时检测尿液钠、肌酐和微量白蛋白的干化学试剂盒,属于医学检验测定技术领域。The invention relates to a method for measuring sodium, creatinine and microalbumin in urine by an enzymatic method, and a dry chemical kit for simultaneously detecting urine sodium, creatinine and microalbumin prepared by using the method, which belongs to the medical examination and measurement technology field.
背景技术Background technique
钠的过度摄入可引起左室肥厚、蛋白尿、动脉硬化等,并对终末期肾衰竭的进展,起着重要的作用。在降低钠摄入的同时不但可以降低血压,也可以减少尿蛋白的排泌。钠在维持正常水分的分布和渗透压方面发挥了中心作用。肾是调节钠和水分、维持酸碱平衡的主要器官。钠可由肾脏自由滤出,其中绝大部分又被重吸收。尿钠的排泄还与饮食含钠盐和机体含水状态密切相关。异常结果:降低:见于肾上腺皮质功能亢进、库欣综合征、原发性醛固酮增多症、充血性心力衰竭等。另外,呕吐、腹泻、胃肠道手术造瘘、大面积烧伤等也可使尿钠排出减少。升高:见于严重的肾盂肾炎、肾小管损伤、糖尿病、急性肾上管坏死(少尿期)、尿崩症、肾上腺皮质功能减退等。Excessive intake of sodium can cause left ventricular hypertrophy, proteinuria, arteriosclerosis, etc., and plays an important role in the progression of end-stage renal failure. While reducing sodium intake, it can not only lower blood pressure, but also reduce the excretion of urinary protein. Sodium plays a central role in maintaining normal water distribution and osmotic pressure. The kidney is the main organ that regulates sodium and water and maintains acid-base balance. Sodium is freely filtered out by the kidneys, and most of it is reabsorbed. Urinary sodium excretion is also closely related to dietary sodium salt and body water status. Abnormal results: decreased: seen in adrenal hyperfunction, Cushing's syndrome, primary aldosteronism, congestive heart failure, etc. In addition, vomiting, diarrhea, gastrointestinal surgical fistula, extensive burns, etc. can also reduce urinary sodium excretion. Elevated: seen in severe pyelonephritis, renal tubular injury, diabetes, acute renal tubular necrosis (oliguria), diabetes insipidus, adrenal insufficiency, etc.
目前电解质钠的测定有化学法、火焰光度法及离子选择电极法,随现代分析技术的发展。化学法已逐渐被灵敏、快速的仪器法所取代。目前大多数医院用的是火焰光度法和离子选择电极法,后者又以其响应快(适合于急诊)、灵敏、结果准确而越来越受化验人员的青睐。近几年又出现了电解质酶法测定方法,可以同其它常规检测项目一起用全自动分析仪进行检测,准确方便,同时也降低了检测成本。酶法测定钠试剂盒国内外已有产品上市,主要是液体双试剂,但仅有少数厂家能够生产,液体试剂很不稳定。At present, the determination of electrolyte sodium includes chemical method, flame photometry and ion selective electrode method, with the development of modern analysis technology. Chemical methods have gradually been replaced by sensitive and rapid instrumental methods. At present, most hospitals use flame photometry and ion selective electrode method, and the latter is more and more favored by laboratory personnel because of its fast response (suitable for emergency), sensitive and accurate results. In recent years, an electrolyte enzyme method has emerged, which can be tested with a fully automatic analyzer together with other routine testing items, which is accurate and convenient, and also reduces the cost of testing. Enzymatic sodium determination kits have been marketed at home and abroad, mainly liquid double reagents, but only a few manufacturers can produce them, and the liquid reagents are very unstable.
肌酐(creatinine,Cre)是肌肉在人体内代谢的产物,每20g肌肉代谢可产生1mg肌酐。肌酐主要由肾小球滤过排出体外。血中肌酐来自外源性和内源性两种,外源性肌酐是肉类食物在体内代谢后的产物;内源性肌酐是体内肌肉组织代谢的产物。在肉类食物摄入量稳定时。身体的肌肉代谢又没有大的变化,肌酐的生成就会比较恒定。尿肌酐主要来自血液,经肾小球过滤后随尿液排出体外。尿肌酐检查可以测定血液经肾小球滤过排出的肌酐含量。尿肌酐值正常范围:8.4~13.25mmol/24h尿或者是40~130mg/dl尿。正常人尿肌酐的日排出量相当稳定,基本不受食物蛋白质含量和尿量的影响。当尿液中肌酐含量显著增高或降低时,则反映出肾功能受到一定程度的损伤。尿肌酐排泄量增高:见于甲状腺功能减退、某些消耗性疾病、肝脏疾患、糖尿病、肢端肥大症、巨人症、发热以及饥饿等。尿肌酐排泄量减少:见于肾脏功能不全、甲状腺功能亢进、贫血、瘫痪、伤寒、破伤风、结核等消耗性疾病及肌肉萎缩和肌肉营养不良等。因此,检查尿肌酐含量的变化对肾功能的变化及治疗可起到重要的参考作用。Creatinine (creatinine, Cre) is the product of muscle metabolism in the human body, and every 20g of muscle metabolism can produce 1mg of creatinine. Creatinine is excreted mainly by glomerular filtration. Blood creatinine comes from both exogenous and endogenous sources. Exogenous creatinine is the product of meat food metabolism in the body; endogenous creatinine is the product of muscle tissue metabolism in the body. When meat food intake is stable. Without major changes in the body's muscle metabolism, the production of creatinine will be relatively constant. Urinary creatinine mainly comes from the blood and is excreted with urine after being filtered by the glomerulus. The urine creatinine test can measure the amount of creatinine excreted by the blood through glomerular filtration. Normal range of urine creatinine value: 8.4-13.25mmol/24h urine or 40-130mg/dl urine. The daily excretion of urinary creatinine in normal people is quite stable, basically not affected by food protein content and urine output. When the creatinine content in the urine is significantly increased or decreased, it reflects that the renal function has been damaged to a certain extent. Increased urinary creatinine excretion: seen in hypothyroidism, certain wasting diseases, liver diseases, diabetes, acromegaly, gigantism, fever, and hunger. Decreased urinary creatinine excretion: seen in renal insufficiency, hyperthyroidism, anemia, paralysis, typhoid, tetanus, tuberculosis and other wasting diseases, muscle atrophy and muscular dystrophy. Therefore, checking the changes of urine creatinine content can play an important reference role in the changes and treatment of renal function.
肌酐常规生化检测方法主要有两大类,一是化学法——碱性苦味酸终点法和碱性苦味酸二点动力学法,因终点法受血清内源性伪阳性和伪阴性干扰物的种类太多,这些干扰物中有的与苦味酸反应比肌酐还快,称为“快干扰物”,如乙酸、乙酰乙酸;有的比肌酐反应慢,称“慢干扰物”,如葡萄糖、某些蛋白质残基等。除了伪阳性干扰外,还存在伪阴性干扰物,常见的是胆红素。胆红素会使肌酐测定结果偏低,当胆红素浓度升至35mg/dl(600μmol/L)时干扰明显。在全国三级甲等医院现已有近半数临床化学实验室将肌酐酶法应用于血/尿肌酐常规检测中。在临床化学方法学发展中酶学方法的运用,使临床化学测定技术有了一个质的飞跃。其核心是酶作用特异性高,使测定的准确性、灵敏度、重复性、线性测量范围等都有了相应的大幅度提高,酶法的普及使采用强酸,强碱的化学方法渐被淘汰。酶促反应条件温和,随着商品试剂盒的发展,再与半自动或全自动生化分析仪配套,使检测快速,简易,高效。近年发展起来的肌酐酶法测定原理,均有商品试剂盒供应,其中有单试剂也有双试剂的不同剂型和规格。酶法提高了检测的特异性,但并非绝对特异性。因此,虽同属酶法但因具体测定原理不同和同一测定原理而选用工具酶的来源、纯度、比活、特别是工具酶作用特异性的差异也存在不同类型和大小不一的干扰。肌酐酶法分析近年来有了迅速发展,酶法测定肌酐试剂盒国内外已有产品上市,主要是液体双试剂,但仅有少数厂家能够生产,液体试剂很不稳定。There are two main types of routine biochemical detection methods for creatinine. One is the chemical method—the basic picric acid endpoint method and the basic picric acid two-point kinetic method. Because the endpoint method is affected by serum endogenous false positive and false negative interference There are too many types, some of these interferers react faster with picric acid than creatinine, called "fast interferers", such as acetic acid, acetoacetic acid; some react slower than creatinine, called "slow interferers", such as glucose, Certain protein residues, etc. In addition to false positive interferences, there are also false negative interferences, the most common being bilirubin. Bilirubin will lower the creatinine measurement results, and the interference will be obvious when the bilirubin concentration rises to 35mg/dl (600μmol/L). Nearly half of the clinical chemistry laboratories in the national tertiary first-class hospitals have applied the creatinine enzyme method to the routine detection of blood/urine creatinine. The application of enzymatic methods in the development of clinical chemistry methodology has made a qualitative leap in clinical chemistry assay technology. Its core is the high specificity of enzyme action, which greatly improves the accuracy, sensitivity, repeatability, and linear measurement range of the determination. The popularization of enzymatic methods makes chemical methods using strong acids and strong bases gradually eliminated. The enzymatic reaction conditions are mild. With the development of commercial kits, it is matched with semi-automatic or fully automatic biochemical analyzers to make the detection fast, simple and efficient. The principle of creatinine enzymatic determination developed in recent years is available in commercial kits, including single reagents and double reagents in different dosage forms and specifications. Enzymatic methods improve the specificity of detection, but not absolute specificity. Therefore, although they belong to the same enzyme method, there are different types and sizes of interference in the selection of tool enzymes due to different specific assay principles and differences in the source, purity, specific activity, and especially the specificity of tool enzyme action. The enzymatic analysis of creatinine has developed rapidly in recent years. Enzymatic creatinine determination kits have been marketed at home and abroad, mainly liquid double reagents, but only a few manufacturers can produce them, and the liquid reagents are very unstable.
尿微量白蛋白是反映肾小球滤过功能的指标,是预示早期的肾脏损害,也反映肌体血管内皮功能紊乱,通过检测尿中的微量白蛋白即可反映血管的功能状况,如能早期治疗肾脏功能尚可能恢复。但是如不早期治疗,这些患者从微量白蛋白尿发展到大量蛋白尿,预示患者的肾脏功能恶化且不可逆转。因此通过检测微量白蛋白尿预测早期肾脏损害和血管功能,进行早期干预性治疗,对于改善高血压或糖尿病所导致的肾脏损害具有重要的临床意义。Urinary microalbumin is an index reflecting glomerular filtration function, which indicates early kidney damage, and also reflects vascular endothelial dysfunction in the body. Microalbumin in urine can reflect the functional status of blood vessels. If it can be treated early Kidney function may still recover. However, without early treatment, these patients develop from microalbuminuria to macroalbuminuria, which indicates that the renal function of the patients deteriorates and is irreversible. Therefore, predicting early kidney damage and vascular function by detecting microalbuminuria, and performing early intervention therapy have important clinical significance for improving kidney damage caused by hypertension or diabetes.
白蛋白检测方法有胶体金法、免疫比浊法、染料亲和化学方法等,目前相关产品均在国内外有产品上市,胶体金法需要专业人员操作,生产工艺复杂,而免疫比浊法检测成本高,需要配套仪器,最简单的方法是染料亲和法,尿液中的白蛋白与磺酞类染料反应形成蓝色产物,呈色深度与尿液中的白蛋白浓度成正比,只需将染料固相在层析膜上,通过仪器或肉眼进行判读。Albumin detection methods include colloidal gold method, immunoturbidimetric method, dye affinity chemical method, etc. At present, related products are on the market at home and abroad. Colloidal gold method requires professional operation, and the production process is complicated. The cost is high and supporting equipment is required. The simplest method is the dye affinity method. Albumin in urine reacts with sulfonphthalein dyes to form a blue product, and the color depth is proportional to the concentration of albumin in urine. The dye is immobilized on the chromatographic membrane and read by instrument or naked eyes.
综上,通过检测尿钠的排泄来预测水钠潴留、肾小球排泄情况及钠盐的摄入情况,对肾源性高血压特别是容量依赖型高血压有较好的预测作用;通过检测尿微量白蛋白的排泄来预测肾脏是否有损伤,肾脏血管是否发生病变改变了肾脏滤过蛋白质(尤其是白蛋白)的功能;微量白蛋白尿也是肾脏和心血管系统改变的早期指征。对于预防肾源性高血压有重要作用。目前还没有能够同时检测尿液中钠、肌酐和微量白蛋白的干化学试剂盒或类似方法的应用,为了适应基层检测机构对尿液中钠、肌酐和微量白蛋白的非定量检测的需要以及检测单位检测硬件配备不足的问题,迫切需要提供一种快速、简便、半定量检测尿液中钠、肌酐和微量白蛋白的半定量检测试剂盒。In conclusion, predicting water and sodium retention, glomerular excretion, and sodium intake by detecting urinary sodium excretion has a good predictive effect on nephrogenic hypertension, especially volume-dependent hypertension; Urinary microalbuminuria is used to predict whether the kidneys are damaged, and whether renal vascular lesions change the function of the kidneys to filter proteins (especially albumin); microalbuminuria is also an early indication of changes in the kidney and cardiovascular system. It plays an important role in preventing nephrogenic hypertension. At present, there is no dry chemical kit or similar method that can detect sodium, creatinine and microalbumin in urine at the same time. Due to the insufficient detection hardware of the detection unit, it is urgent to provide a fast, simple and semi-quantitative detection kit for semi-quantitative detection of sodium, creatinine and microalbumin in urine.
发明内容Contents of the invention
本发明的目的是提供一种同时检测尿液钠、肌酐和微量白蛋白的干化学试剂盒。The purpose of the present invention is to provide a dry chemical kit for simultaneously detecting urine sodium, creatinine and microalbumin.
本发明提供的一种同时检测尿液中钠、肌酐和微量白蛋白的试剂盒,包括:(1)具有钠反应孔、肌酐反应孔和微量白蛋白反应孔的反应基板;The present invention provides a kit for simultaneously detecting sodium, creatinine and microalbumin in urine, comprising: (1) a reaction substrate with sodium reaction wells, creatinine reaction wells and microalbumin reaction wells;
(2)钠稀释液、肌酐稀释液;(2) Sodium diluent, creatinine diluent;
(3)具有不同浓度钠离子标准显色、不同浓度肌酐标准显色和不同浓度微量白蛋白标准显色的标准比色板。(3) Standard color guides with different concentrations of sodium ion standard color development, different concentrations of creatinine standard color development and different concentrations of microalbumin standard color development.
所述钠反应孔从孔底部起依次放有底物垫和酶垫;The sodium reaction wells are sequentially provided with substrate pads and enzyme pads from the bottom of the wells;
所述底物垫由底物溶液滴加在载体上制备而成;底物溶液以100-1000mmol/L pH7.5-9.0的缓冲液为溶剂,含有0.001-0.01g/mL的β-半乳糖苷酶底物、20-80mmol/L的穴醚、0.005%-50%的稳定剂和0.005%-50%的表面活性剂;The substrate pad is prepared by dripping the substrate solution on the carrier; the substrate solution uses 100-1000mmol/L pH7.5-9.0 buffer as solvent and contains 0.001-0.01g/mL of β-galactose Glycosidase substrate, 20-80mmol/L cryptin, 0.005%-50% stabilizer and 0.005%-50% surfactant;
所述酶垫由酶溶液滴加在载体上制备而成;酶溶液以100-1000mmol/L pH 7.0-9.0的缓冲液为溶剂,含有200-3000U/mL的β-半乳糖苷酶和0.01-100g/L酶稳定剂。The enzyme pad is prepared by dripping the enzyme solution on the carrier; the enzyme solution uses 100-1000mmol/L pH 7.0-9.0 buffer as the solvent, contains 200-3000U/mL β-galactosidase and 0.01- 100g/L enzyme stabilizer.
优选地,所述酶溶液以100-1000mmol/L pH 7.0-9.0的缓冲液为溶剂,含有500-1500U/mL的β-半乳糖苷酶和10-20g/L稳定剂。Preferably, the enzyme solution uses 100-1000mmol/L buffer solution with pH 7.0-9.0 as solvent, contains 500-1500U/mL β-galactosidase and 10-20g/L stabilizer.
上述缓冲液均可选自磷酸钾缓冲液、Tris-HCl缓冲液或PIPES缓冲液的一种或几种。The above buffers can be selected from one or more of potassium phosphate buffer, Tris-HCl buffer or PIPES buffer.
优选地,底物溶液的缓冲液为800-1000mmol/L pH8.0-9.0的Tris-HCl缓冲液;酶溶液的缓冲液为100-200mmol/L pH 7.0-8.0的Tris-HCl缓冲液。Preferably, the buffer of the substrate solution is 800-1000mmol/L Tris-HCl buffer at pH 8.0-9.0; the buffer of the enzyme solution is 100-200mmol/L Tris-HCl buffer at pH 7.0-8.0.
底物垫中含有的β-半乳糖苷酶底物为O-硝基-β-D-吡喃糖苷(ONPG)、5-溴-4-氯-3-吲哚-β-D-吡喃半乳糖苷(x-gal)、氯酚红-β-D-吡喃半乳糖苷(CPRG)、PNPG、IPTG。The β-galactosidase substrates contained in the substrate pad are O-nitro-β-D-pyranoside (ONPG), 5-bromo-4-chloro-3-indole-β-D-pyranoside Galactoside (x-gal), chlorophenol red-β-D-galactopyranoside (CPRG), PNPG, IPTG.
优选地,β-半乳糖苷酶底物为5-溴-4-氯-3-吲哚-β-D-吡喃半乳糖苷(x-gal)和氯酚红-β-D-吡喃半乳糖苷(CPRG)。Preferably, the β-galactosidase substrates are 5-bromo-4-chloro-3-indole-β-D-galactopyranoside (x-gal) and chlorophenol red-β-D-pyranoside Galactoside (CPRG).
底物垫中含有的穴醚为4,7,13,16,21-五氧杂-1,10-二氮杂双环[8.8.5]廿三烷、18-Crown-8或者是15-Crown-5中的一种或几种。优选地,所述穴醚为4,7,13,16,21-五氧杂-1,10-二氮杂双环[8.8.5]廿三烷(Kryptofix)The cryptane contained in the substrate pad is 4,7,13,16,21-pentoxa-1,10-diazabicyclo[8.8.5]tricosane, 18-Crown-8 or 15-Crown One or more of -5. Preferably, the cryptane is 4,7,13,16,21-pentoxa-1,10-diazabicyclo[8.8.5]tricosane (Kryptofix)
底物垫中含有的稳定剂为D-海藻糖、蔗糖、葡聚糖T70、β-环糊精、牛血清白蛋白、甘露醇、α-乳糖、聚乙二醇、明胶、肌醇、木糖或阿拉伯糖醇中的一种或几种,优选稳定剂为蔗糖和D-海藻糖;The stabilizers contained in the substrate pad are D-trehalose, sucrose, dextran T70, β-cyclodextrin, bovine serum albumin, mannitol, α-lactose, polyethylene glycol, gelatin, inositol, wood One or more of sugar or arabitol, the preferred stabilizers are sucrose and D-trehalose;
底物垫中含有的表面活性剂为吐温80、吐温20、Triton X-100、NP40或山梨醇中的一种或多种,优选表面活性剂为吐温80。The surfactant contained in the substrate pad is one or more of Tween 80, Tween 20, Triton X-100, NP40 or sorbitol, preferably the surfactant is Tween 80.
酶垫中含有的稳定剂为D-海藻糖、蔗糖、葡聚糖T70、β-环糊精、牛血清白蛋白、甘露醇、聚乙二醇、明胶、肌醇、木糖、阿拉伯糖醇、α-乳糖、马来酸、酒石酸或者柠檬酸中的一种或多种,优选稳定剂为α-乳糖和葡聚糖T70。The stabilizers contained in the enzyme pad are D-trehalose, sucrose, dextran T70, β-cyclodextrin, bovine serum albumin, mannitol, polyethylene glycol, gelatin, inositol, xylose, arabitol , one or more of α-lactose, maleic acid, tartaric acid or citric acid, preferably the stabilizer is α-lactose and dextran T70.
本发明提供的一种同时检测尿液中钠、肌酐和微量白蛋白的试剂盒中的反应基板中的肌酐反应孔从孔底部起依次放有下垫和上垫;The creatinine reaction hole in the reaction substrate in the kit for simultaneously detecting sodium, creatinine and microalbumin in urine provided by the present invention has a lower pad and an upper pad sequentially from the bottom of the hole;
所述下垫由下垫溶液滴加在载体上制备而成;下垫溶液以水为溶剂,含有10-2000U/mL的过氧化物酶、10-1000U/mL肌酐酰胺水解酶,0.1%-10%的显色剂1,5-500mmol/L pH 6.0-8.0的缓冲液,0.005%-50%的稳定剂;The underpad is prepared by dripping the underpad solution on the carrier; the underpad solution uses water as a solvent, contains 10-2000U/mL peroxidase, 10-1000U/mL creatinine amide hydrolase, 0.1%- 10% chromogen 1, 5-500mmol/L pH 6.0-8.0 buffer, 0.005%-50% stabilizer;
优选地,下垫溶液中过氧化物酶活力为800-1500U/mL,肌酐酰胺水解酶活力为500-1000U/mL;Preferably, the activity of peroxidase in the underlying solution is 800-1500U/mL, and the activity of creatinine amide hydrolase is 500-1000U/mL;
所述显色剂1为4-氨基安替吡啉、3-甲基-2-苯并噻唑啉酮腙盐酸盐水合物(MBTH)中的一种或多种;优选所述显色剂1为0.5%-2%的4-氨基安替吡啉;The color developer 1 is one or more of 4-aminoantipyridine, 3-methyl-2-benzothiazolinone hydrazone hydrochloride hydrate (MBTH); preferably the color developer 1 0.5%-2% of 4-aminoantipyridine;
所述5-500mmol/L pH 6.0-8.0的缓冲液为磷酸钠缓冲液、磷酸钾缓冲液、Tris-HCl缓冲液或PIPES缓冲液的一种或几种,优选所述缓冲液为50-200mmol/L pH 7.0-8.0的磷酸钾缓冲液;The buffer of 5-500mmol/L pH 6.0-8.0 is one or more of sodium phosphate buffer, potassium phosphate buffer, Tris-HCl buffer or PIPES buffer, preferably the buffer is 50-200mmol /L potassium phosphate buffer solution with pH 7.0-8.0;
所述0.005%-50%的稳定剂为D-海藻糖、蔗糖、葡聚糖T70、β-环糊精、牛血清白蛋白、甘露醇、聚乙二醇、明胶、肌醇、木糖、阿拉伯糖醇、α-乳糖、马来酸、酒石酸或者柠檬酸中的一种或多种,优选所述稳定剂为1%-20%蔗糖和肌醇。The 0.005%-50% stabilizer is D-trehalose, sucrose, dextran T70, β-cyclodextrin, bovine serum albumin, mannitol, polyethylene glycol, gelatin, inositol, xylose, One or more of arabitol, α-lactose, maleic acid, tartaric acid or citric acid, preferably the stabilizer is 1%-20% sucrose and inositol.
本发明的同时检测尿液中钠、肌酐和微量白蛋白的试剂盒中的反应基板中的肌酐反应孔的上垫由上垫溶液滴加在载体上制备而成;上垫溶液以水为溶剂,含有10-2000U/mL的肌氨酸氧化酶、10-2000U/mL的肌酸脒基水解酶,0.1%-10%的显色剂2,5-500mmol/L pH6.0-8.0的缓冲液,0.005%-50%的稳定剂;The upper pad of the creatinine reaction hole in the reaction substrate in the kit for simultaneously detecting sodium, creatinine and microalbumin in urine of the present invention is prepared by dropping the upper pad solution on the carrier; the upper pad solution uses water as a solvent , containing 10-2000U/mL sarcosine oxidase, 10-2000U/mL creatine amidinohydrolase, 0.1%-10% chromogen 2, 5-500mmol/L pH6.0-8.0 buffer Liquid, 0.005%-50% stabilizer;
优选地,上垫溶液中肌氨酸氧化酶活力为10-500U/mL,肌酸脒基水解酶活力为20-500U/mL。Preferably, the activity of sarcosine oxidase in the upper pad solution is 10-500U/mL, and the activity of creatine amidinohydrolase is 20-500U/mL.
所述显色剂2为2,4,6-三溴-3-羟基苯甲酸(TBHB)、3,5-二氯-2-羟基苯磺酸(DCHBS)、N-乙基-N-(2-羟基-3-磺丙基)-3-甲基苯胺(TOOS)、N-乙基-N-(3-磺丙基)-3-甲基苯胺(TOPS)、N,N-双(4-磺丁基)-3-甲基苯胺二钠盐中的一种或多种。优选显色剂2为1%-10%的TBHB、DCHBS中的一种或多种。The developer 2 is 2,4,6-tribromo-3-hydroxybenzoic acid (TBHB), 3,5-dichloro-2-hydroxybenzenesulfonic acid (DCHBS), N-ethyl-N-( 2-Hydroxy-3-sulfopropyl)-3-methylaniline (TOOS), N-ethyl-N-(3-sulfopropyl)-3-methylaniline (TOPS), N,N-bis( One or more of 4-sulfobutyl)-3-methylaniline disodium salts. Preferably, the developer 2 is one or more of 1%-10% TBHB and DCHBS.
所述5-500mmol/L pH6.0-8.0的缓冲液为磷酸钠缓冲液、磷酸钾缓冲液、Tris-HCl缓冲液或PIPES缓冲液的一种或几种,优选缓冲液为50-200mmol/L pH7.0-8.0的磷酸钾缓冲液;The buffer of the 5-500mmol/L pH6.0-8.0 is one or more of sodium phosphate buffer, potassium phosphate buffer, Tris-HCl buffer or PIPES buffer, preferably the buffer is 50-200mmol/L Potassium phosphate buffer solution of L pH7.0-8.0;
所述0.005%-50%的稳定剂为D-海藻糖、蔗糖、葡聚糖T70、β-环糊精、牛血清白蛋白、甘露醇、聚乙二醇、明胶、肌醇、木糖、阿拉伯糖醇、α-乳糖、马来酸、酒石酸或者柠檬酸中的一种或多种,优选稳定剂为1%-20%蔗糖和葡聚糖T70。The 0.005%-50% stabilizer is D-trehalose, sucrose, dextran T70, β-cyclodextrin, bovine serum albumin, mannitol, polyethylene glycol, gelatin, inositol, xylose, One or more of arabitol, α-lactose, maleic acid, tartaric acid or citric acid, preferably the stabilizer is 1%-20% sucrose and dextran T70.
本发明提供的一种同时检测尿液中钠、肌酐和微量白蛋白的试剂盒中的反应基板中的微量白蛋白反应孔内有显色垫;所述显色垫由显色染料溶液滴加在载体上制备而成;所述的显色染料溶液以水为溶剂,含有0.02-20mg/mL的染料、0.1-2mol/L pH 1.5-3.0的缓冲液、0.1-2%的分散剂;In a kit for simultaneously detecting sodium, creatinine and microalbumin in urine provided by the present invention, there is a chromogenic pad in the microalbumin reaction hole in the reaction substrate; the chromogenic pad is added dropwise by a chromogenic dye solution Prepared on a carrier; the chromogenic dye solution uses water as a solvent, contains 0.02-20mg/mL dye, 0.1-2mol/L pH 1.5-3.0 buffer, and 0.1-2% dispersant;
所述染料选自5’5”-2-硝基-3’,3”-二碘-3,4,5,6-四溴苯酚磺酞(DIDNTB)、溴酚蓝、四溴酚蓝中的一种或多种;优选染料为1-5mg/mL的DIDNTB。The dye is selected from 5'5"-2-nitro-3',3"-diiodo-3,4,5,6-tetrabromophenolsulfonphthalein (DIDNTB), bromophenol blue, and tetrabromophenol blue One or more of DIDNTB; the preferred dye is 1-5 mg/mL of DIDNTB.
所述缓冲液为磷酸钠缓冲液、磷酸钾缓冲液、柠檬酸缓冲溶液、Tris-HCl缓冲液或PIPES缓冲液的一种或几种;优选缓冲液为1.5-2mol/L pH 1.5-3.0的柠檬酸缓冲液。The buffer is one or more of sodium phosphate buffer, potassium phosphate buffer, citrate buffer, Tris-HCl buffer or PIPES buffer; the preferred buffer is 1.5-2mol/L pH 1.5-3.0 citrate buffer.
所述分散剂选自聚乙烯醇、三乙基己基磷酸、十二烷基硫酸钠、甲基戊醇、纤维素衍生物、聚丙烯酰胺、古尔胶中的一种或几种。优选所述分散剂为0.5-1.5%的聚乙烯醇。The dispersant is selected from one or more of polyvinyl alcohol, triethylhexyl phosphoric acid, sodium lauryl sulfate, methyl amyl alcohol, cellulose derivatives, polyacrylamide, and gull gum. Preferably, the dispersant is 0.5-1.5% polyvinyl alcohol.
本发明的一种同时检测尿液中钠、肌酐和微量白蛋白的试剂盒中的反应基板中的钠反应孔、肌酐反应孔和微量白蛋白反应孔所采用的载体为滤纸、玻璃纤维或者层析纸。The carrier used in the sodium reaction well, creatinine reaction well and microalbumin reaction well in the reaction substrate in a kit for simultaneously detecting sodium, creatinine and microalbumin in urine of the present invention is filter paper, glass fiber or layer Analysis paper.
本发明试剂盒的钠反应孔、肌酐反应孔和微量白蛋白反应孔的尺寸可为优选 The size of the sodium reaction well, the creatinine reaction well and the microalbumin reaction well of the kit of the present invention can be preferred
本发明提供的一种同时检测尿液中钠、肌酐和微量白蛋白的试剂盒中,所述钠稀释液为pH 8.0-9.0的0.1-1.5mol/L的磷酸钠缓冲液、磷酸钾缓冲液、柠檬酸缓冲溶液、Tris-HCl缓冲液或PIPES缓冲液的一种或几种;优选所述缓冲液为pH 8.0-8.8的0.5-1.2mol/L的Tris-HCl缓冲液。In a kit for simultaneously detecting sodium, creatinine and microalbumin in urine provided by the present invention, the sodium diluent is 0.1-1.5 mol/L sodium phosphate buffer and potassium phosphate buffer with a pH of 8.0-9.0 , one or more of citric acid buffer solution, Tris-HCl buffer or PIPES buffer; preferably the buffer is 0.5-1.2mol/L Tris-HCl buffer with pH 8.0-8.8.
所述肌酐稀释液为pH 6.5-8.0的0.1-1.2mol/L的磷酸钠缓冲液、磷酸钾缓冲液、柠檬酸缓冲溶液、Tris-HCl缓冲液或PIPES缓冲液的一种或几种。优选所述缓冲液为pH7.0-8.0的0.5-1.2mol/L的磷酸钾缓冲液。The creatinine diluent is one or more of 0.1-1.2 mol/L sodium phosphate buffer solution, potassium phosphate buffer solution, citric acid buffer solution, Tris-HCl buffer solution or PIPES buffer solution with a pH of 6.5-8.0. Preferably, the buffer is a 0.5-1.2 mol/L potassium phosphate buffer with a pH of 7.0-8.0.
本发明提供了上述试剂盒在同时检测尿液中钠含量、肌酐含量和微量白蛋白含量中的应用。The invention provides the application of the above reagent kit in simultaneous detection of sodium content, creatinine content and microalbumin content in urine.
本领域技术人员应当理解,本领域中,检测尿液中钠含量为检测尿液中钠离子含量。考虑到试剂盒保存的需要,所制备的反应垫必须具备相当高的稳定性,发明人在大量实验研究的基础上,确定了上述酶液、显色液和各种底物液的组成及其配方,使得试剂盒具有理想的稳定性,能够在实际应用中推广。Those skilled in the art should understand that in this field, detecting sodium content in urine is detecting sodium ion content in urine. Considering the needs of kit preservation, the prepared reaction pad must have a relatively high stability. On the basis of a large number of experimental studies, the inventor has determined the composition of the above-mentioned enzyme solution, chromogenic solution and various substrate solutions and their The formula makes the kit have ideal stability and can be popularized in practical applications.
本发明中,钠离子和肌酐指标用来衡量预测24小时摄入钠的变化,肌酐和微量白蛋白指标用来衡量肾脏损害,是高血压、心血管病人危险因素的辅助诊断。基于这些研究结果,本发明建立了一种简便、快速的同时检测尿钠、肌酐和微量白蛋白的干化学测定试剂盒。In the present invention, the sodium ion and creatinine indexes are used to measure and predict the change of sodium intake in 24 hours, and the creatinine and microalbumin indexes are used to measure kidney damage, which is an auxiliary diagnosis of risk factors for hypertension and cardiovascular patients. Based on these research results, the present invention establishes a simple and rapid dry chemical assay kit for simultaneous detection of urinary sodium, creatinine and microalbumin.
采用上述技术方案,本发明的优点在于:本发明解决了液体试剂的不稳定问题,通过加入激活剂、酶稳定剂等物质,在既保证试剂垫上试剂稳定的前提下,又能够快速的提高反应的灵敏度和准确性;试剂盒操作简便快速,准确性高,适用于临床常规检测特别是临床病人床旁检测使用,进而指导合理临床用药。只需将收集的尿液进行稀释,加到对应反应孔中,反应一段时间进行比色,测定被测尿液所在钠值(肌酐和微量白蛋白值)区间范围,评估测试者摄入钠的多少,不需大型仪器设备,操作简便,可在医院急诊室、基层医疗与保健单位及病人家庭使用。本发明试剂盒避免了单独观察单一指标产生的片面性和干扰因素;而且相对的,收集单次尿具有简单、快捷等优点。Adopting the above technical scheme, the advantage of the present invention is that: the present invention solves the instability problem of liquid reagents, and by adding activators, enzyme stabilizers and other substances, it can quickly improve the reaction rate under the premise of ensuring the stability of the reagents on the reagent pad. Sensitivity and accuracy; the kit is easy and fast to operate, with high accuracy, and is suitable for routine clinical testing, especially bedside testing of clinical patients, so as to guide rational clinical medication. It only needs to dilute the collected urine, add it to the corresponding reaction well, react for a period of time for colorimetry, measure the sodium value (creatinine and microalbumin value) range of the tested urine, and evaluate the sodium intake of the tester. How much, no need for large-scale equipment, easy to operate, can be used in hospital emergency rooms, primary medical and health care units and patients' families. The kit of the invention avoids the one-sidedness and interference factors caused by observing a single index alone; and relatively, the collection of a single urine has the advantages of simplicity and speed.
具体实施方式Detailed ways
以下实施例进一步说明本发明的内容,但不应理解为对本发明的限制。在不背离本发明精神和实质的情况下,对本发明方法、步骤或条件所作的修改或替换,均属于本发明的范围。The following examples further illustrate the content of the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and essence of the present invention, any modifications or substitutions made to the methods, steps or conditions of the present invention fall within the scope of the present invention.
若未特别指明,实施例中所用的技术手段为本领域技术人员所熟知的常规手段。Unless otherwise specified, the technical means used in the embodiments are conventional means well known to those skilled in the art.
实施例1同时检测尿钠、肌酐和微量白蛋白的干化学试剂盒的制备Embodiment 1 simultaneously detects the preparation of the dry chemical kit of urine sodium, creatinine and trace albumin
本实施例的同时检测尿钠、肌酐和微量白蛋白的试剂盒包括:具有钠反应孔、肌酐反应孔和微量白蛋白反应孔的反应基板;钠稀释液、肌酐稀释液;具有不同浓度钠离子标准显色、不同浓度肌酐标准显色和不同浓度微量白蛋白标准显色的标准比色板。The kit for simultaneous detection of urinary sodium, creatinine and microalbumin in this embodiment includes: a reaction substrate with sodium reaction wells, creatinine reaction wells and microalbumin reaction wells; sodium diluent and creatinine diluent; sodium ions with different concentrations Standard color guides for standard color development, standard color development of different concentrations of creatinine and standard color development of different concentrations of microalbumin.
上述同时检测尿钠、肌酐和微量白蛋白试剂盒的制备方法如下:The preparation method of the above-mentioned simultaneous detection of urine sodium, creatinine and microalbumin test kit is as follows:
(1)反应基板的结构:(1) The structure of the reaction substrate:
本实施例的反应基板选自ABS工程塑料制成,其上设有钠反应孔、肌酐反应孔和微量白蛋白反应孔;反应孔的尺寸为 The reaction substrate of the present embodiment is selected from ABS engineering plastics and is provided with sodium reaction holes, creatinine reaction holes and microalbumin reaction holes; the size of the reaction holes is
(2)钠反应孔中底物垫的制备:(2) Preparation of the substrate pad in the sodium reaction well:
钠反应孔从孔底部起依次放有底物垫和酶垫。The sodium reaction wells are provided with substrate pads and enzyme pads sequentially from the bottom of the wells.
底物垫由底物溶液1μL滴加在层析纸上,避光条件下,25℃流动空气干燥4小时后制得,密封保存在4℃。The substrate pad was dropwise added with 1 μL of substrate solution on On chromatography paper, it was prepared after drying in flowing air at 25°C for 4 hours under dark conditions, and sealed and stored at 4°C.
底物溶液以1000mmol/L pH 8.7的Tris-HCl缓冲液为溶剂,含有0.005g/mL的β-半乳糖苷酶底物CPRG、50mmol/L的穴醚【4,7,13,16,21-五氧杂-1,10-二氮杂双环[8.8.5]廿三烷(Kryptofix)】、10%的D-海藻糖和0.05%的吐温80。The substrate solution uses 1000mmol/L Tris-HCl buffer with pH 8.7 as solvent, contains 0.005g/mL β-galactosidase substrate CPRG, 50mmol/L cryptin [4,7,13,16,21 - Pentaoxa-1,10-diazabicyclo[8.8.5]tricosane (Kryptofix)], 10% D-trehalose and 0.05% Tween 80.
酶垫由酶溶液1μL滴加在层析纸上,避光条件下,25℃流动空气干燥4小时后制备而成,密封保存在4℃。Enzyme pads were added dropwise with 1 μL of enzyme solution on On chromatography paper, it is prepared after drying in the flowing air at 25°C for 4 hours under the condition of avoiding light, and it is sealed and stored at 4°C.
酶溶液以100mmol/L pH 7.5的Tris-HCl缓冲液为溶剂,含有800U/mL的β-半乳糖苷酶和10g/L酶稳定剂The enzyme solution uses 100mmol/L Tris-HCl buffer solution with pH 7.5 as solvent, contains 800U/mL β-galactosidase and 10g/L enzyme stabilizer
(3)肌酐反应孔中下垫和上垫的制备:(3) Preparation of lower pad and upper pad in the creatinine reaction well:
肌酐反应孔从孔底部起依次放有下垫和上垫。The creatinine reaction well has a lower pad and an upper pad in order from the bottom of the well.
下垫的制备:将1μL下垫溶液滴加在层析纸上,避光条件下,25℃流动空气干燥4小时后,密封保存在4℃。Preparation of underpad: Add 1 μL of underpad solution dropwise on On the chromatographic paper, under the condition of avoiding light, dry at 25°C with flowing air for 4 hours, and then seal and store at 4°C.
下垫溶液以水为溶剂,含有1000U/mL的过氧化物酶、800U/mL肌酐酰胺水解酶,1%的4-氨基安替吡啉,100mmol/L pH 7.3的磷酸钾缓冲液,10%的蔗糖。The underlying solution uses water as a solvent, containing 1000U/mL peroxidase, 800U/mL creatinine amide hydrolase, 1% 4-aminoantipyridine, 100mmol/L potassium phosphate buffer at pH 7.3, 10% of sucrose.
上垫的制备:将1μL上垫溶液滴加在层析纸上,避光条件下,25℃流动空气干燥4小时后,密封保存在4℃。Preparation of the upper pad: Add 1 μL of the upper pad solution dropwise on the On the chromatographic paper, under the condition of avoiding light, dry at 25°C with flowing air for 4 hours, and then seal and store at 4°C.
上垫溶液以水为溶剂,含有300U/mL的肌氨酸氧化酶、200U/mL的肌酸脒基水解酶,1%的TBHB,100mmol/L pH 7.3的磷酸钾缓冲液,10%的蔗糖。The upper pad solution uses water as the solvent, contains 300U/mL sarcosine oxidase, 200U/mL creatine amidinohydrolase, 1% TBHB, 100mmol/L potassium phosphate buffer at pH 7.3, 10% sucrose .
(4)微量白蛋白反应孔中显色垫的制备:显色垫由1μL显色染料溶液滴加在层析纸上,避光条件下,25℃流动空气干燥4小时后,密封保存在4℃。(4) Preparation of chromogenic pads in microalbumin reaction wells: 1 μL chromogenic dye solution was added dropwise to the chromogenic pads. On the chromatographic paper, under the condition of avoiding light, dry at 25°C with flowing air for 4 hours, and then seal and store at 4°C.
所述的显色染料溶液以水为溶剂,含有2mg/mL的染料5’5”-2-硝基-3’,3”-二碘-3,4,5,6-四溴苯酚磺酞(DIDNTB)、1mol/L pH 2.5的柠檬酸缓冲液、1%的聚乙烯醇。The chromogenic dye solution uses water as a solvent and contains 2 mg/mL of dye 5'5"-2-nitro-3',3"-diiodo-3,4,5,6-tetrabromophenolsulfonphthalein (DIDNTB), 1mol/L pH 2.5 citrate buffer, 1% polyvinyl alcohol.
(5)将步骤(2)~(4)制备的各反应垫填入相应的反应孔中,用冲压机压实,然后贴上铝箔贴条,装入铝箔袋中,即得具有钠反应孔、肌酐反应孔和微量白蛋白反应孔的反应基板。(5) Fill the reaction pads prepared in steps (2) to (4) into the corresponding reaction wells, compact them with a punching machine, then paste aluminum foil strips, and put them into aluminum foil bags to obtain sodium reaction wells. , creatinine reaction wells and reaction substrates for microalbumin reaction wells.
(6)钠稀释液的制备:0.8mol/L pH 8.7的Tris-HCl缓冲溶液1000mL,充分混匀后,分装在滴瓶中保存。(6) Preparation of sodium diluent: 1000 mL of 0.8 mol/L Tris-HCl buffer solution with pH 8.7, mix thoroughly, and store in dropper bottles.
肌酐稀释液的制备:1mol/L pH 7.3的磷酸钾缓冲溶液1000mL,充分混匀后,分装在滴瓶中保存。Preparation of creatinine dilution: 1000mL of 1mol/L potassium phosphate buffer solution with pH 7.3, mix thoroughly, and store in dropper bottles.
(7)标准比色板的制备:配制钠、肌酐和微量白蛋白标准液,具体配制方法如下:(7) Preparation of standard color guide: prepare standard solution of sodium, creatinine and microalbumin, the specific preparation method is as follows:
1)基础尿液制备收集尿液:收集三日内未摄入高钠尿液5份(晨尿8:00-9:00最佳),采用本产品按照说明书测定尿中钠浓度应(应<20mmol/L)、肌酐浓度(应<0.15g/L),白蛋白浓度(应<30mg/L),充分混匀,经0.45μm膜抽滤,作为基础尿液,2℃~8℃保存。同时基础尿液可以作为“阴性样品”使用。1) Basic urine preparation Collect urine: collect 5 copies of high-sodium urine that have not been ingested within three days (8:00-9:00 in the morning urine is the best), use this product to measure the sodium concentration in urine according to the instructions (should be < 20mmol/L), creatinine concentration (should be <0.15g/L), albumin concentration (should be <30mg/L), mix thoroughly, filter through a 0.45μm membrane, use as basic urine, and store at 2°C to 8°C. At the same time, basic urine can be used as a "negative sample".
2)标准液的配制2) Preparation of standard solution
(a)氯化钠标准液的配制称取0.585g氯化钠加入到2ml纯化水中溶解,制成5000mmol/L氯化钠标准液。(a) Preparation of sodium chloride standard solution Weigh 0.585 g of sodium chloride and add it to 2 ml of purified water for dissolution to prepare a 5000 mmol/L sodium chloride standard solution.
(b)肌酐标准液的配制称取0.1g肌酐加入到2ml纯化水中溶解,制成50g/L肌酐标准液。(b) Preparation of creatinine standard solution Weigh 0.1g of creatinine and add it into 2ml of purified water to dissolve to prepare 50g/L creatinine standard solution.
(c)白蛋白标准液的配制称取10mg人血清白蛋白加入到2ml纯化水中溶解,制成5000mg/L人血清白蛋白标准液。(c) Preparation of albumin standard solution Weigh 10 mg of human serum albumin and add it to 2 ml of purified water to dissolve to prepare a 5000 mg/L human serum albumin standard solution.
3)各色标标本的制备3) Preparation of color standard specimens
(a)钠标准色板的标本的制备:依次量取基础尿液4、20、40μl放入三个离心管中,按顺序加入996、980、960μl 5000mmol/L氯化钠标准液,混匀,密封保存在2℃~8℃,24小时内使用,终浓度见下表1。(a) Preparation of sodium standard swatches: Measure 4, 20, and 40 μl of basic urine into three centrifuge tubes in sequence, add 996, 980, and 960 μl of 5000 mmol/L sodium chloride standard solution in sequence, and mix well , sealed and stored at 2°C to 8°C, and used within 24 hours, the final concentration is shown in Table 1 below.
(b)肌酐标准色板的样本的制备:依次量取基础尿液3、10、20、40μl放入四个离心管中,按顺序加入997、990、980、960μl50g/L肌酐标准液,混匀,密封保存在2℃~8℃,24小时内使用,终浓度见下表1。(b) Preparation of samples of creatinine standard swatches: Measure 3, 10, 20, and 40 μl of basic urine in turn and put them into four centrifuge tubes, add 997, 990, 980, and 960 μl of 50 g/L creatinine standard solution in sequence, mix Mix well, seal and store at 2°C to 8°C, and use within 24 hours. The final concentration is shown in Table 1 below.
(c)人白蛋白标准色板的样本的制备:依次量取基础尿液6、16、32、60μl放入四个离心管中,按顺序加入994、984、968、940μl 5000mg/L人血清白蛋白标准液,混匀,密封保存在2℃~8℃,24小时内使用,终浓度见下表1。(c) Preparation of samples of human albumin standard color plate: Measure 6, 16, 32, and 60 μl of basic urine into four centrifuge tubes, and add 994, 984, 968, and 940 μl of 5000 mg/L human serum in sequence Albumin standard solution, mixed well, sealed and stored at 2°C to 8°C, used within 24 hours, the final concentration is shown in Table 1 below.
表1各色标标本浓度表Table 1 Concentration table of each color standard sample
将上述不同色标的标准液滴加到反应孔上进行显色,由3-5个人目测,并与标准比色板进行比较,选出标准色,进行印刷,并进行验证,经过反复几次,最终确定标准比色板。Add the above-mentioned standard solutions of different color standards to the reaction wells for color development, visually inspect by 3-5 people, and compare with the standard color guide, select the standard color, print it, and verify it. After repeated several times, Finalize the standard color guide.
实施例2本发明的能同时检测尿液钠、肌酐和微量白蛋白的干化学试剂盒的应用Embodiment 2 Application of the dry chemical kit capable of simultaneously detecting urine sodium, creatinine and microalbumin of the present invention
本发明的试剂盒是一种半定量检测尿液钠、肌酐和微量白蛋白的干化学试剂盒,可以对临床上高血压病人的尿液样本进行检测,也可对健康人群的尿液样本进行检测,以检查待测人群的盐摄取量是否超标,可作为高血压病人的诊断、鉴别诊断和疗效评价的辅助指标,也可作为健康人群日常饮食控制盐摄取量的辅助工具。The kit of the present invention is a dry chemical kit for semi-quantitative detection of urine sodium, creatinine and microalbumin, which can detect clinically the urine samples of hypertensive patients, and can also detect the urine samples of healthy people. It can be used as an auxiliary indicator for the diagnosis, differential diagnosis and curative effect evaluation of hypertensive patients, and can also be used as an auxiliary tool for healthy people to control their salt intake in their daily diet.
本发明实施例1制备的试剂盒的具体使用方法如下:The specific method of use of the kit prepared in Example 1 of the present invention is as follows:
1)在使用时,首先将试剂盒从保存温度下取出,平衡到室温开始使用;1) When in use, first take the kit out of the storage temperature, equilibrate to room temperature and start using;
2)撕掉铝箔包装,取出反应基板;2) Tear off the aluminum foil packaging and take out the reaction substrate;
3)尿液处理:取25μl尿液分别加入钠、肌酐稀释液:充分混匀;稀释液与尿液的体积比为1:20-35(本实施例选用1:30)。3) Urine treatment: Take 25 μl of urine and add sodium and creatinine diluent respectively: mix thoroughly; the volume ratio of diluent to urine is 1:20-35 (1:30 is used in this embodiment).
4)吸取上述稀释后的尿液25μl分别于钠反应孔、肌酐反应孔;微量白蛋白直接测定。4) Pipette 25 μl of the above-mentioned diluted urine into the sodium reaction well and the creatinine reaction well respectively; directly measure microalbumin.
5)在干浴器(设置温度为48℃)上反应7min,将反应结果与比色板进行比较,可以半定量得到被测物浓度。本领域技术人员应当理解,根据本领域的现有技术,在使用其他保温容器如培养箱、烘箱、水浴容器等的设置温度为35-50℃的条件下反应后,也能够实现结果的对比判断。5) React in a dry bath (set temperature at 48°C) for 7 minutes, compare the reaction result with the color guide, and obtain the concentration of the analyte semi-quantitatively. Those skilled in the art should understand that, according to the existing technology in this field, after using other heat preservation containers such as incubators, ovens, water bath containers, etc., to react at a temperature of 35-50 ° C, the comparative judgment of the results can also be realized .
采用本发明的试剂盒对临床上对每日食盐量<6克,6~12克以及>12克的90位志愿者(每30名对应不同的食盐量组)进行检测,检测结果准确率达100%。The test kit of the present invention is used to detect clinically 90 volunteers (30 corresponding to different salt groups) whose daily salt content is less than 6 grams, 6-12 grams and >12 grams, and the accuracy of the detection results is up to 100%.
本发明的试剂盒性能稳定,保质期为18个月。The performance of the kit of the invention is stable, and the shelf life is 18 months.
采用本发明的试剂盒对临床上尿液钠、肌酐和微量白蛋白进行检测,与商品化的尿液钠、肌酐和微量白蛋白定量试剂盒进行比对,本发明试剂盒检测结果准确率达95%以上。The kit of the present invention is used to detect clinical urine sodium, creatinine and microalbumin, and compared with commercialized urine sodium, creatinine and microalbumin quantitative kits, the accuracy of the detection results of the kit of the present invention is up to above 95.
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510683512.7A CN105388146B (en) | 2015-10-20 | 2015-10-20 | Kit that is a kind of while detecting sodium in urine, creatinine and microalbumin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510683512.7A CN105388146B (en) | 2015-10-20 | 2015-10-20 | Kit that is a kind of while detecting sodium in urine, creatinine and microalbumin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105388146A CN105388146A (en) | 2016-03-09 |
CN105388146B true CN105388146B (en) | 2018-08-17 |
Family
ID=55420676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510683512.7A Active CN105388146B (en) | 2015-10-20 | 2015-10-20 | Kit that is a kind of while detecting sodium in urine, creatinine and microalbumin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105388146B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106353511A (en) * | 2016-08-19 | 2017-01-25 | 基蛋生物科技股份有限公司 | Urinary microalbumin (U-mALb)/urinary creatinine (U-Cr) integrated assay bigeminy strip and preparation method thereof |
CN106645758B (en) * | 2017-01-03 | 2019-03-22 | 长沙中生众捷生物技术有限公司 | The Test paper of creatinine |
CN106645132B (en) * | 2017-02-09 | 2023-07-18 | 厦门信道生物技术有限公司 | Test paper for detecting lactose content in sample and preparation method of test paper |
CN107358033B (en) * | 2017-06-26 | 2019-03-08 | 广东省人民医院(广东省医学科学院) | Appraisal procedure for the intake of Patients with Chronic Kidney Disease dietary protein |
CN108120714B (en) * | 2017-12-20 | 2020-11-27 | 吉林省汇酉生物技术股份有限公司 | Reagent for detecting microalbumin in urine and application thereof |
TW201940878A (en) * | 2018-03-23 | 2019-10-16 | 保生國際生醫股份有限公司 | Detecting method and system thereof |
CN109856131B (en) * | 2019-01-22 | 2022-02-18 | 杭州联晟生物科技有限公司 | Test card for simultaneously detecting uric acid, creatinine and urea in sample and preparation method thereof |
CN109799331A (en) * | 2019-03-18 | 2019-05-24 | 湖南海源医疗科技股份有限公司 | A kind of Tumor specific factor TSGF analysis strip |
CN112577940A (en) * | 2019-09-30 | 2021-03-30 | 厦门大学 | Method for rapidly and quantitatively detecting concentration of creatinine in urine at low cost |
CN110716047B (en) * | 2019-10-24 | 2023-03-17 | 杭州康知生物科技有限公司 | Urine detection kit matched with kidney disease early-screening small-sized full-automatic analyzer |
CN111579797A (en) * | 2020-05-27 | 2020-08-25 | 艾康生物技术(杭州)有限公司 | Detection test paper and application thereof |
CN113238060B (en) * | 2021-05-08 | 2022-10-11 | 迈克生物股份有限公司 | Kit for predicting or diagnosing myocarditis |
CN113376383A (en) * | 2021-06-10 | 2021-09-10 | 吉林基蛋生物科技有限公司 | Preparation method of Vc interference resistant urine creatinine test paper |
CN113418916A (en) * | 2021-07-02 | 2021-09-21 | 安徽惠邦生物工程有限公司 | Creatinine quantitative rapid detection test strip and preparation method thereof |
CN115201134B (en) * | 2022-09-15 | 2022-12-27 | 吉林大学第一医院 | Creatinine detection kit resistant to piceatannol interference and application thereof |
CN118746681A (en) * | 2024-07-10 | 2024-10-08 | 万有生化智能科技(深圳)有限公司 | A non-invasive colorimetric test strip for simultaneous measurement of albumin, creatinine and uric acid |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4864615B2 (en) * | 2006-03-28 | 2012-02-01 | 栄研化学株式会社 | Multi-item test strips and methods for detecting test substances in specimens |
JP5572359B2 (en) * | 2009-10-07 | 2014-08-13 | 株式会社テクノメデイカ | Urine substance concentration measuring device |
CN101865911A (en) * | 2010-03-16 | 2010-10-20 | 苏州市玮琪生物科技有限公司 | Urine creatine quantitative test card |
JP5925026B2 (en) * | 2011-04-28 | 2016-05-25 | アークレイ株式会社 | Dry specimen for creatinine measurement and creatinine measurement method |
CN103630535A (en) * | 2013-12-03 | 2014-03-12 | 上海科华生物工程股份有限公司 | Dry chemical test paper for quantitatively determining content of human blood albumin |
CN103901034B (en) * | 2014-04-29 | 2016-07-06 | 中国科学院苏州生物医学工程技术研究所 | A kind of detectable bar detecting microalbumin in urine and preparation method thereof |
CN104198408A (en) * | 2014-08-14 | 2014-12-10 | 上海睿康生物科技有限公司 | Detection kit for determining content of creatinine in serum by enzymic method |
CN104849270A (en) * | 2015-05-22 | 2015-08-19 | 汇征联合(北京)医疗器械有限公司 | Reagent for determining sodium chloride content in urine, test paper strip thereof, preparation method thereof and purpose thereof |
-
2015
- 2015-10-20 CN CN201510683512.7A patent/CN105388146B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN105388146A (en) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105388146B (en) | Kit that is a kind of while detecting sodium in urine, creatinine and microalbumin | |
CN105334211B (en) | It is a kind of while detect the kit of sodium and creatinine in urine | |
EP1532267B1 (en) | Test strip for detection of analyte and methods of use | |
US5516700A (en) | Automated urinalysis method | |
JP5646323B2 (en) | Method for measuring components in blood using hemolyzed whole blood and kit thereof | |
Kasidas et al. | Continuous-flow assay for urinary oxalate using immobilised oxalate oxidase | |
CN106198527A (en) | A kind of ascorbic acid interference multi-term urine analysis test paper | |
CN109856128A (en) | A kind of urine glucose detection test paper and preparation method thereof of ascorbic acid interference | |
CN103048282B (en) | Detection method of bilirubin and detection kit | |
CN117607418A (en) | Reagent and test strip for detecting uric acid, and preparation method and application thereof | |
CN108593633A (en) | A kind of Test paper for quickly detecting saliva uric acid | |
CN104673878B (en) | Kit for measuring concentration ratio of glycated albumin and albumin by virtue of single system | |
JP3569139B2 (en) | Diazonium ion assay reagent and method of use | |
CN114441516A (en) | A kind of uric acid detection kit and preparation method thereof | |
CN105021543A (en) | Alpha-amylase detection reagent and application thereof | |
CN108037281A (en) | A kind of cardic fatty acid binding protein immunologic function test reagent and its preparation and detection method | |
CN113311171A (en) | Method for detecting glycated serum albumin by using boric acid affinity principle | |
CN108333175B (en) | Total cholesterol detection method | |
CN110187106A (en) | A kind of Multilayer film dry plate and its measuring method quantitative determining alpha-amylase activity | |
CN118688189A (en) | Test paper card for semi-quantitative testing of ethanol, preparation method and test card | |
CN108593905A (en) | A kind of digoxin immune detection reagent and its preparation and detection method | |
CN102901711A (en) | Sarcosine oxidase method for quantitatively detecting sarcosine and detection kit | |
CN114660285A (en) | Kit for measuring preeclampsia, preparation method and application | |
CN108226147B (en) | Urine microalbumin detection reagent strip and preparation method thereof | |
JPH0687798B2 (en) | Method for measuring calcium in body fluids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160412 Address after: 100044 No. 11 South Main Street, Beijing, Xizhimen Applicant after: PEKING UNIVERSITY PEOPLE'S Hospital Applicant after: BEIJING ZHONGSHENG JINYU DIAGNOSIS TECHNOLOGY Co.,Ltd. Address before: 102200 No. 6, Spark Street, Changping District science and Technology Park, Beijing Applicant before: BEIJING ZHONGSHENG JINYU DIAGNOSIS TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230313 Address after: 102200 Standard Workshop No. 6 Xinghuo Street, Changping District Science and Technology Park, Beijing, on the east side of the third floor and the west side of the second floor Patentee after: BEIJING ZHONGSHENG JINYU DIAGNOSIS TECHNOLOGY Co.,Ltd. Address before: 100044 No. 11 South Main Street, Beijing, Xizhimen Patentee before: PEKING UNIVERSITY PEOPLE'S Hospital Patentee before: BEIJING ZHONGSHENG JINYU DIAGNOSIS TECHNOLOGY Co.,Ltd. |